Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-191-3 | CAS number: 7789-80-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- chronic toxicity: oral
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- publication
- Title:
- The Toxicology of Potassium and Sodium lodates II. Subacute Toxicity of Potassium lodate in Mice and Guinea Pigs
- Author:
- STEWART H. WEBSTER, MARY E. RICE, BENJAMIN HIGHMAN, AND EDWARD F. STOHLMAN
- Year:
- 1 959
- Bibliographic source:
- TOXICOLOGY 1, 87-96 (1959)
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other:
- Principles of method if other than guideline:
- Toxicity of potassium iodate was assessed in Swiss mice
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Potassium iodate
- EC Number:
- 231-831-9
- EC Name:
- Potassium iodate
- Cas Number:
- 7758-05-6
- IUPAC Name:
- potassium iodate
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material : Potassium iodate
- Molecular formula : KIO3
- Molecular weight : 214.001
- Substance type : Inorganic
- Physical state : Solid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- Swiss
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: No data available
- Age at study initiation: No data available
- Weight at study initiation: No data available
- Fasting period before study: No data available
- Housing: Mice were was housed in glass jars embedded with saw dust.
- Diet (e.g. ad libitum): Purina Laboratory Chow, ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimatization period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data available
- Humidity (%) :No data available
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): No data available
IN-LIFE DATES: From: To: No data available
Administration / exposure
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
KIO3 was administered to comparable groups of mice in their drinking water.
DIET PREPARATION
- Rate of preparation of diet (frequency): N/A
- Mixing appropriate amounts with (Type of food): N/A
- Storage temperature of food: N/A
VEHICLE
- Justification for use and choice of vehicle (if other than water): Water
- Concentration in vehicle: 0, 0.05, 0.10, 0.25, 0.50 or 0.75% per day
- Amount of vehicle (if gavage): No data available
- Lot/batch no. (if required): No data available
- Purity: No data available - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 104 days
- Frequency of treatment:
- Daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0.05%, 0.10%, 0.25%, 0.50%, and 0.75% (71.428, 142.857, 357.142, 714.285, 1071.428 mg/kg bw/day)
Basis:
nominal in water
- No. of animals per sex per dose:
- 76
- Control animals:
- yes, concurrent vehicle
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: No
- Time schedule:
- Cage side observations checked in table [No.?] were included.
DETAILED CLINICAL OBSERVATIONS: No
- Time schedule:
BODY WEIGHT: Yes
- Time schedule for examinations: Twice weekly
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): No
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No
FOOD EFFICIENCY: No
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: Twice weekly
OPHTHALMOSCOPIC EXAMINATION: No
- Time schedule for examinations:
- Dose groups that were examined:
HAEMATOLOGY: Yes
- Time schedule for collection of blood: No data available
- Anaesthetic used for blood collection: No data available
- Animals fasted: No data available
- How many animals: On all surviving animals.
- Parameters examined: Potassium iodate and potassium iodide
CLINICAL CHEMISTRY: No
- Time schedule for collection of blood:
- Animals fasted:
- How many animals:
- Parameters examined:
URINALYSIS: No
- Time schedule for collection of urine:
- Metabolism cages used for collection of urine:
- Animals fasted:
- Parameters examined:
NEUROBEHAVIOURAL EXAMINATION: No
- Time schedule for examinations:
- Dose groups that were examined:
- Battery of functions tested: sensory activity / grip strength / motor activity / other: - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
Survivors were killed with ether at the end of the experiment for pathologic study. Autopsies were performed also on all animals that died during the experiment.
HISTOPATHOLOGY: Yes
Tissues saved for microscopic study were fixed in 10% aqueous buffered formalin (pH 7.0). - Statistics:
- Statistical tests were carried out on the hematologic data using Student’s t-test.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- Clinical signs and mortality:
Three animals in the 0.75% per day group died during the first week.
Body weight and weight gain
Increased in body weight observed in all dose groups at 104th day.
Food consumption and compound intake
No data available
Water consumption and compound intake
At the beginning of the experiment the 0.75%/day KIO3 group drank only about 25% as much as the controls, but later the consumption increased to between 60% and 70% of the control group. However, controls and mice given lower concentrations of iodate drank less liquid as they grew larger. Accordingly, it seems reasonable to conclude that the restriction of liquid by the mice given the higher iodate concentrations may be due to the bad taste and/or toxic effects of the drinking water. It is likely that the reduced consumption of liquid is accompanied by a decrease in the amount of food ingested or vice versa, which would result in a decreased growth rate.
Haematology
Decreased levels of RBC, hemoglobin, hematocrit and WBC count were observed as compared to control.
Clinical chemistry
No data available
Organ weights
No data available
Gross pathology
No gross abnormalities attributable to iodate were found at autopsy. In only three of twenty-four iodate animals was the pH of the stomach contents increased above 4.
Histopathology
None of the animals showed histologic alterations in the gastric mucosa. Microscopic studies showed hemosiderin deposits in the renal convoluted tubules in nearly all mice which received 0.50%/day KIO3 for 16 weeks. Similar changes were seen in only a few mice which received distilled water, iodide, or lower concentrations of iodate. The deposition of hemosiderin, in addition to the reduced blood values is strong evidence of increased hemolysis due to the iodate. No other significant changes were found.
Effect levels
open allclose all
- Dose descriptor:
- LOEL
- Effect level:
- 714.285 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: Body weight, water consumption and increased hemolysis.
- Dose descriptor:
- NOAEL
- Effect level:
- 357.142 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: Water consumption and increased hemolysis.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- LOEL was considered to be 0.50% (714.285 mg/kg bw/day) while NOAEL was considered to be 0.25% (357.142 mg/kg bw/day )per day when Swiss female mice were exposed to KIO3.
- Executive summary:
In a toxicity study, the effect of potassium iodate (KIO3) was assessed in Swiss female mice. The mice were exposed to KIO3in drinking water on a daily basis at dose concentration of 0,0.05, 0.10, 0.25%, 0.50 or 0.75% per day for 104 days. Increasedin body weight was observed in all dose groups at the end of the study. Decreased levels of RBC, hemoglobin, hematocrit and WBC count were also observed as well as deposition ofhemosiderin in the renal convoluted tubules in nearly all mice receiving 0.50%/day KIO3for 16 weeks. Deposition of hemosiderin, in addition to the reduced blood values, is strong evidence of increased hemolysis due to the iodate treatment. Hence, LOEL was considered to be 0.50% (714.285 mg/kg bw/day) whereas NOAEL was considered to be 0.25% (357.142 mg/kg bw/day ) in Swiss female mice when exposed to KIO3in drinking water on a daily basis for 16 weeks.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.